U.S. biotech to apply artificial intelligence to UK genome study

CHICAGO (Reuters) – Berg, a private company that uses artificial intelligence to discover new drugs and diagnostics, will help England’s national genomics project mine DNA and health data from thousands of British citizens for potential drug targets.

—> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail